English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17939/22958 (78%)
Visitors : 7369761      Online Users : 169
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.csmu.edu.tw:8080/ir/handle/310902500/18993


    Title: Gene therapy for human glioblastoma using neurotropic JC virus-like particles as a gene delivery vector
    Authors: CN, Chao
    YH, Yang
    MS, Wu
    MC, Chou
    CY, Fang
    MC, Lin
    CK, Tai
    CH, Shen
    PL, Chen
    Chang, D
    Wang, M
    Contributors: 中山醫學大學
    Date: 2018-12-01
    Issue Date: 2018-03-21T09:57:01Z (UTC)
    Publisher: Nature Publishing Group
    ISSN: 20452322
    Abstract: Glioblastoma multiforme (GBM), the most common malignant brain tumor, has a short period of survival even with recent multimodality treatment. The neurotropic JC polyomavirus (JCPyV) infects glial cells and oligodendrocytes and causes fatal progressive multifocal leukoencephalopathy in patients with AIDS. In this study, a possible gene therapy strategy for GBM using JCPyV virus-like particles (VLPs) as a gene delivery vector was investigated. We found that JCPyV VLPs were able to deliver the GFP reporter gene into tumor cells (U87-MG) for expression. In an orthotopic xenograft model, nude mice implanted with U87 cells expressing the near-infrared fluorescent protein and then treated by intratumoral injection of JCPyV VLPs carrying the thymidine kinase suicide gene, combined with ganciclovir administration, exhibited significantly prolonged survival and less tumor fluorescence during the experiment compared with controls. Furthermore, JCPyV VLPs were able to protect and deliver a suicide gene to distal subcutaneously implanted U87 cells in nude mice via blood circulation and inhibit tumor growth. These findings show that metastatic brain tumors can be targeted by JCPyV VLPs carrying a therapeutic gene, thus demonstrating the potential of JCPyV VLPs to serve as a gene therapy vector for the far highly treatment-refractory GBM. © 2018 The Author(s).
    URI: https://www.doi.org/10.1038/s41598-018-19825-w
    https://ir.csmu.edu.tw:8080/ir/handle/310902500/18993
    Relation: Scientific Reports Volume 8, Issue 1, 1 December 2018, 論文編號 2213
    Appears in Collections:[醫學系] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML360View/Open


    SFX Query

    All items in CSMUIR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback